top of page

OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG

Product details

Registration number: SIN16852P

Classification: Prescription Only

Active ingredients:

  • Nivolumab
  • Relatlimab

Strength:

  • 240mg per vial
  • 80mg per vial

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

ATC code: L01XY03

HSA approval date: 31 August 2023

Manufacturer(s): Catalent Indiana LLC

Manufacturing country/countries: UNITED STATES

What are the HSA registration number and classification for OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG?

According to the HSA dataset updated 7 August 2026:

Registration number: SIN16852P

Classification: Prescription Only

Source for this answer

What active ingredients and strength are recorded for OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG?

According to the HSA dataset updated 7 August 2026:

Active ingredients:

  • Nivolumab
  • Relatlimab

Strength:

  • 240mg per vial
  • 80mg per vial

Ingredients and strengths are listed separately as recorded by HSA; their positions do not establish a one-to-one match. This is not a dosing instruction.

Source for this answer

What dosage form and route are recorded for OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG?

According to the HSA dataset updated 7 August 2026:

Dosage form: INFUSION, SOLUTION CONCENTRATE

Route: INTRAVENOUS

Source for this answer

Who is the recorded registrant for OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG?

According to the HSA dataset updated 7 August 2026:

Registrant: BRISTOL-MYERS SQUIBB (SINGAPORE) PTE. LTD.

Source for this answer

Which manufacturers and countries are listed for OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG?

According to the HSA dataset updated 7 August 2026:

Manufacturer(s): Catalent Indiana LLC

Manufacturing country/countries: UNITED STATES

Source for this answer

Where can I look up OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG in the HSA register?

Open HSA’s therapeutic product register and search for registration number SIN16852P or the exact product name OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG. The general register link does not preselect this product.

Source for this answer

What are the source dates for this OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG record?

This record is from HSA’s List of Registered Therapeutic Products on data.gov.sg. Dataset update: 7 August 2026. Retrieval date: 13 November 2026.

The dataset date is a snapshot date, not a separate current-register check for every product. Later direct checks are recorded separately.

Source for this answer

Has this OPDUALAG CONCENTRATE FOR SOLUTION FOR INFUSION 240MG/80MG record had a separate HSA register check?

No separate current-register check is recorded for this product. Its presence in the imported dataset does not establish its current registration status.

Search the HSA register using SIN16852P for the latest record.

Source for this answer

Sources and dates

HSA dataset: 2026. Updated: 13 November 2026.

Factual product information only; no dosing, treatment or suitability advice.

Updated and reviewed by: Dr Joel Lim MBChB UK (PG Dip Dermatology), Resident Physician.

bottom of page